These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
509 related articles for article (PubMed ID: 9616187)
1. Biotransformation of tolterodine, a new muscarinic receptor antagonist, in mice, rats, and dogs. Andersson SH; Lindgren A; Postlind H Drug Metab Dispos; 1998 Jun; 26(6):528-35. PubMed ID: 9616187 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of tolterodine, a muscarinic receptor antagonist, in mouse, rat and dog. Interspecies relationship comparing with human pharmacokinetics. Påhlman I; Kankaanranta S; Palmér L Arzneimittelforschung; 2001 Feb; 51(2):134-44. PubMed ID: 11258043 [TBL] [Abstract][Full Text] [Related]
3. Tolterodine, a new muscarinic receptor antagonist, is metabolized by cytochromes P450 2D6 and 3A in human liver microsomes. Postlind H; DanielsonA ; Lindgren A; Andersson SH Drug Metab Dispos; 1998 Apr; 26(4):289-93. PubMed ID: 9531513 [TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of central muscarinic receptor binding activity by oxybutynin, tolterodine and darifenacin used to treat overactive bladder. Oki T; Kageyama A; Takagi Y; Uchida S; Yamada S J Urol; 2007 Feb; 177(2):766-70. PubMed ID: 17222678 [TBL] [Abstract][Full Text] [Related]
5. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of tolterodine in man: a new drug for the treatment of urinary bladder overactivity. Brynne N; Stahl MM; Hallén B; Edlund PO; Palmér L; Höglund P; Gabrielsson J Int J Clin Pharmacol Ther; 1997 Jul; 35(7):287-95. PubMed ID: 9247842 [TBL] [Abstract][Full Text] [Related]
7. Influence of CYP2D6 polymorphism on the pharmacokinetics and pharmacodynamic of tolterodine. Brynne N; Dalén P; Alván G; Bertilsson L; Gabrielsson J Clin Pharmacol Ther; 1998 May; 63(5):529-39. PubMed ID: 9630826 [TBL] [Abstract][Full Text] [Related]
8. Tissue distribution of tolterodine, a muscarinic receptor antagonist, and transfer into fetus and milk in mice. Påhlman I; d'Argy R; Nilvebrant L Arzneimittelforschung; 2001 Feb; 51(2):125-33. PubMed ID: 11258042 [TBL] [Abstract][Full Text] [Related]
9. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes. Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo metabolism of desogestrel in several species. Verhoeven CH; Krebbers SF; Wagenaars GN; Vos RM Drug Metab Dispos; 1998 Sep; 26(9):927-36. PubMed ID: 9733673 [TBL] [Abstract][Full Text] [Related]
11. Studies on the preparation, characterization and pharmacological evaluation of tolterodine PLGA microspheres. Sun F; Sui C; Teng L; Liu X; Teng L; Meng Q; Li Y Int J Pharm; 2010 Sep; 397(1-2):44-9. PubMed ID: 20600717 [TBL] [Abstract][Full Text] [Related]
12. Characterization of muscarinic receptor binding and inhibition of salivation after oral administration of tolterodine in mice. Oki T; Maruyama S; Takagi Y; Yamamura HI; Yamada S Eur J Pharmacol; 2006 Jan; 529(1-3):157-63. PubMed ID: 16316647 [TBL] [Abstract][Full Text] [Related]
13. Biotransformation of the anti-angiogenic compound SU5416. Antonian L; Zhang H; Yang C; Wagner G; Shawver LK; Shet M; Ogilvie B; Madan A; Parkinson A Drug Metab Dispos; 2000 Dec; 28(12):1505-12. PubMed ID: 11095590 [TBL] [Abstract][Full Text] [Related]
14. In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans. Lang D; Freudenberger C; Weinz C Drug Metab Dispos; 2009 May; 37(5):1046-55. PubMed ID: 19196846 [TBL] [Abstract][Full Text] [Related]
15. Flutamide metabolism in four different species in vitro and identification of flutamide metabolites in human patient urine by high performance liquid chromatography/tandem mass spectrometry. Tevell A; Lennernäs H; Jönsson M; Norlin M; Lennernäs B; Bondesson U; Hedeland M Drug Metab Dispos; 2006 Jun; 34(6):984-92. PubMed ID: 16540588 [TBL] [Abstract][Full Text] [Related]
16. Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human. Halpin RA; Ulm EH; Till AE; Kari PH; Vyas KP; Hunninghake DB; Duggan DE Drug Metab Dispos; 1993; 21(6):1003-11. PubMed ID: 7905377 [TBL] [Abstract][Full Text] [Related]
17. Metabolism of prazosin in rat, dog, and human liver microsomes and cryopreserved rat and human hepatocytes and characterization of metabolites by liquid chromatography/tandem mass spectrometry. Erve JC; Vashishtha SC; DeMaio W; Talaat RE Drug Metab Dispos; 2007 Jun; 35(6):908-16. PubMed ID: 17353349 [TBL] [Abstract][Full Text] [Related]
18. Tolterodine does not affect memory assessed by passive-avoidance response test in mice. Cappon GD; Bush B; Newgreen D; Finch GL; Alper RH Eur J Pharmacol; 2008 Jan; 579(1-3):225-8. PubMed ID: 18031724 [TBL] [Abstract][Full Text] [Related]
19. Biotransformation of felodipine in liver microsomes from rat, dog, and man. Bäärnhielm C; Backman A; Hoffmann KJ; Weidolf L Drug Metab Dispos; 1986; 14(5):613-8. PubMed ID: 2876870 [TBL] [Abstract][Full Text] [Related]
20. Biotransformation of sufentanil in liver microsomes of rats, dogs, and humans. Lavrijsen K; Van Houdt J; Van Dyck D; Hendrickx J; Lauwers W; Hurkmans R; Bockx M; Janssen C; Meuldermans W; Heykants J Drug Metab Dispos; 1990; 18(5):704-10. PubMed ID: 1981724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]